sample_name,pass_qc,cell_line,library,ip,patient_id,sample_id,storage_condition,condition,number_cells,atac_seq_batch,experiment_name,technical_replicate,organism,data_source,flowcell,lane,BSF_name,clinical_centre,sample_type,cell_type,sample_origin,original_patient_id,timepoint,experiment,ibrutinib_cohort,ibrutinib_treatment,del11q,del13q,del17p,tri12,treatment_response,timepoint_name,treatment_dosage,patient_gender,patient_birth_date,patient_death_date,patient_last_checkup_date,diagnosis_date,diagnosis_disease,hospital,diagnosis_change_date,diagnosis_stage_rai,diagnosis_stage_binet,under_treatment,under_concurrent_treatment,concurrent_treatment_regimen,concurrent_treatment_date,concurrent_treatment_response,concurrent_treatment_end,treatment_date,treatment_regimen,treatment_response,treatment_end_date,relapse,treatment_1_date,treatment_1_regimen,treatment_1_duration,treatment_1_response,treatment_2_date,treatment_2_regimen,treatment_2_duration,treatment_2_response,treatment_3_date,treatment_3_regimen,treatment_3_duration,treatment_3_response,treatment_4_date,treatment_4_regimen,treatment_4_response,treatment_end_date.1,ighv_gene,ighv_homology,ighv_mutation_status,CD38_cells_percentage,CD38_positive,CD38_measurement_date,CD38_changed,ZAP70_cells_percentage,ZAP70_positive,ZAP70_monoallelic_methylation,CD49d_cells_percentage,CD49d_positive,sample_collection_date,lymp_count,%CLL_cells,mutations,sample_shippment_batch,sample_cell_number,sample_processing_date,sample_viability
CLL_ATAC-seq_AKH1_M4693_ATAC39s1_hg19,1,CLL,ATAC-seq,,AKH1,M4693,,,,ATAC39,ATAC39s1,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4693_M4693_ATAC39s1,vienna,patient,CLL,in_vivo,CLL18,1,AKH1-Ibrutinib,1,before,0,0,0,1,PR,before Ibrutinib,,F,02/11/1948,,09/10/2015,01/01/2001,CLL,AKH,,II,B,0,,,,,,12/12/2014,,PR,,,12/12/2014,,,,,,,,,,,,,,,,,90,1,27,1,09/01/2013,,,,,,,02/01/2014,5,,,,2800000,,
CLL_ATAC-seq_AKH1_M4699_ATAC39s2_hg19,1,CLL,ATAC-seq,,AKH1,M4699,,,,ATAC39,ATAC39s2,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4699_M4699_ATAC39s2,vienna,patient,CLL,in_vivo,CLL18,2,AKH1-Ibrutinib,1,after,0,0,0,1,PR,after Ibrutinib,,F,02/11/1948,,09/10/2015,01/01/2001,CLL,AKH,,II,B,1,,,,,,12/12/2014,,PR,,,12/12/2014,,,,,,,,,,,,,,,,,90,1,27,1,09/01/2013,,,,,,,10/06/2014,6.6,,,,5000000,,96.11
CLL_ATAC-seq_AKH1_M4713_ATAC39s3_hg19,1,CLL,ATAC-seq,,AKH1,M4713,,,,ATAC39,ATAC39s3,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4713_M4713_ATAC39s3,vienna,patient,CLL,in_vivo,CLL18,3,AKH1-Ibrutinib,1,after,0,0,0,1,PR,after Ibrutinib before Zydelig,,F,02/11/1948,,09/10/2015,01/01/2001,CLL,AKH,,II,B,1,,,,,,12/12/2014,,PR,,,12/12/2014,,,,,,,,,,,,,,,,,90,1,27,1,09/01/2013,,,,,,,12/12/2014,5.33,,tri12 (19%),,2300000,,
CLL_ATAC-seq_AKH1_M4727_ATAC39s4_hg19,1,CLL,ATAC-seq,,AKH1,M4727,,,,ATAC39,ATAC39s4,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4727_M4727_ATAC39s4,vienna,patient,CLL,in_vivo,CLL18,4,AKH1-Zydelig,0,,,,,,PR,after Zydelig,,F,02/11/1948,,09/10/2015,01/01/2001,CLL,AKH,,II,B,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,90,1,27,1,09/01/2013,,,,,,,10/07/2015,5.64,,,,5000000,,94.08
CLL_ATAC-seq_AKH1_M4731_ATAC39s5_hg19,1,CLL,ATAC-seq,,AKH1,M4731,,,,ATAC39,ATAC39s5,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4731_M4731_ATAC39s5,vienna,patient,CLL,in_vivo,CLL18,5,AKH1-Zydelig,0,,,,,,PR,after Zydelig,,F,02/11/1948,,09/10/2015,01/01/2001,CLL,AKH,,II,B,1,,,,,,18/11/2014,,PR,05/02/2015,,18/11/2014,,,,,,,,,,,,,,,,,90,1,27,1,09/01/2013,,,,,,,09/10/2015,6.1,,,,3300000,,97.25
CLL_ATAC-seq_AKH10_M4705_ATAC40s11_hg19,1,CLL,ATAC-seq,,AKH10,M4705,,,,ATAC40,ATAC40s11,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4705_M4705_ATAC40s11,vienna,patient,CLL,in_vivo,CLL8,1,AKH10-Ibrutinib,1,before,0,0,1,0,PR,before Ibrutinib,,M,12/08/1930,6/6/2015,12/09/2013,,CLL,AKH,,II,B,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,96,1,,,,,,,,,,20/10/2014,,,del17p (70%),,5000000,,96.45
CLL_ATAC-seq_AKH10_M4710_ATAC40s12_hg19,1,CLL,ATAC-seq,,AKH10,M4710,,,,ATAC40,ATAC40s12,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4710_M4710_ATAC40s12,vienna,patient,CLL,in_vivo,CLL8,2,AKH10-Ibrutinib,1,after,0,0,1,0,PR,after Ibrutinib,,M,12/08/1930,,12/09/2013,,CLL,AKH,,II,B,1,,,,,,29/07/2014,,PR,15/04/2015,,29/07/2014,,,,,,,,,,,,,,,,,96,1,,,,,,,,,,09/12/2014,,,,,5000000,,90.87
CLL_ATAC-seq_AKH11_M4691_ATAC40s13_hg19,1,CLL,ATAC-seq,,AKH11,M4691,,,,ATAC40,ATAC40s13,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4691_M4691_ATAC40s13,vienna,patient,CLL,in_vivo,CLL9,1,AKH11-Ibrutinib,1,before,0,0,0,0,SD,before Ibrutinib-early,,M,23/12/1954,,11/04/2014,01/12/2006,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,91,1,2,0,01/12/2006,,,,,,,27/11/2013,17,,,,5000000,,97.12
CLL_ATAC-seq_AKH11_M4696_ATAC40s14_hg19,1,CLL,ATAC-seq,,AKH11,M4696,,,,ATAC40,ATAC40s14,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4696_M4696_ATAC40s14,vienna,patient,CLL,in_vivo,CLL9,2,AKH11-Ibrutinib,1,before,0,0,0,0,SD,before Ibrutinib,,M,23/12/1954,,11/04/2014,01/12/2006,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,91,1,2,0,01/12/2006,,,,,,,11/04/2014,46,,normal,,5000000,,96.08
CLL_ATAC-seq_AKH11_M4728_ATAC40s15_hg19,1,CLL,ATAC-seq,,AKH11,M4728,,,,ATAC40,ATAC40s15,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4728_M4728_ATAC40s15,vienna,patient,CLL,in_vivo,CLL9,3,AKH11-Ibrutinib,1,after,0,0,0,0,SD,after Ibrutinib,,M,23/12/1954,,11/04/2014,01/12/2006,CLL,AKH,,IV,C,1,,,,,,18/02/2013,,SD,01/08/2013,,18/02/2013,,,,,,,,,,,,,,,,,91,1,2,0,01/12/2006,,,,,,,22/07/2015,16.84,,,,5000000,,94.94
CLL_ATAC-seq_AKH12_M4684_ATAC40s16_hg19,1,CLL,ATAC-seq,,AKH12,M4684,,,,ATAC40,ATAC40s16,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4684_M4684_ATAC40s16,vienna,patient,CLL,in_vivo,CLL10,1,AKH12-Ibrutinib,1,before,1,0,0,0,PR,before Ibrutinib,,M,02/03/1942,,10/04/2014,01/01/1999,CLL,AKH,,IV,C,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,100,0,3,0,21/01/2013,,,,,,,18/02/2013,9,,del11q (88%),,5000000,,96.37
CLL_ATAC-seq_AKH12_M4688_ATAC40s17_hg19,1,CLL,ATAC-seq,,AKH12,M4688,,,,ATAC40,ATAC40s17,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4688_M4688_ATAC40s17,vienna,patient,CLL,in_vivo,CLL10,2,AKH12-Ibrutinib,1,after,1,0,0,0,PR,after Ibrutinib,,M,02/03/1942,,10/04/2014,01/01/1999,CLL,AKH,,IV,C,1,,,,,,10/11/2014,,PR,,,10/11/2014,,,,,,,,,,,,,,,,,100,0,3,0,21/01/2013,,,,,,,25/03/2013,26,,,,5000000,,94.47
CLL_ATAC-seq_AKH13_M3086_ATAC40s20_hg19,1,CLL,ATAC-seq,,AKH13,M3086,,,,ATAC40,ATAC40s20,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M3086_M3086_ATAC40s20,vienna,patient,CLL,in_vivo,CLL20,1,AKH13-TRU+Benda,0,,,,,,SD,before TRU+Benda,,M,08/06/1955,,31/03/2014,01/03/2008,CLL,AKH,,II,B,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,,,14,0,27/09/2011,,,,,,,17/08/2011,109,,,,5000000,,92.95
CLL_ATAC-seq_AKH13_M3152_ATAC40s21_hg19,0,CLL,ATAC-seq,,AKH13,M3152,,,,ATAC40,ATAC40s21,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M3152_M3152_ATAC40s21,vienna,patient,CLL,in_vivo,CLL20,2,AKH13-TRU+Benda,0,,,,,,SD,after TRU+Benda,,M,08/06/1955,,31/03/2014,01/03/2008,CLL,AKH,,II,B,0,,,,,,16/12/2013,,SD,,,16/12/2013,,,,,,,,,,,,,,,,,,,14,0,27/09/2011,,,,,,,17/10/2011,40,,,,5000000,,89.32
CLL_ATAC-seq_AKH13_M3427_ATAC40s22_hg19,1,CLL,ATAC-seq,,AKH13,M3427,,,,ATAC40,ATAC40s22,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M3427_M3427_ATAC40s22,vienna,patient,CLL,in_vivo,CLL20,3,AKH13-TRU+Benda,0,,,,,,SD,after TRU+Benda,,M,08/06/1955,,31/03/2014,01/03/2008,CLL,AKH,,II,B,1,,,,,,16/12/2013,,SD,,,16/12/2013,,,,,,,,,,,,,,,,,,,14,0,27/09/2011,,,,,,,07/08/2012,23,,del13p (14%),,5000000,,89.48
CLL_ATAC-seq_AKH13_M4692_ATAC40s18_hg19,1,CLL,ATAC-seq,,AKH13,M4692,,,,ATAC40,ATAC40s18,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4692_M4692_ATAC40s18,vienna,patient,CLL,in_vivo,CLL20,4,AKH13-Ibrutinib,1,before,0,0,0,0,SD,before Ibrutinib,,M,08/06/1955,,31/03/2014,01/03/2008,CLL,AKH,,II,B,1,,,,,,28/11/2013,,SD,25/03/2015,,28/11/2013,,,,,,,,,,,,,,,,,,,14,0,27/09/2011,,,,,,,12/12/2013,208,,,,5000000,,93.36
CLL_ATAC-seq_AKH13_M4694_ATAC40s19_hg19,1,CLL,ATAC-seq,,AKH13,M4694,,,,ATAC40,ATAC40s19,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4694_M4694_ATAC40s19,vienna,patient,CLL,in_vivo,CLL20,5,AKH13-Ibrutinib,1,after,0,0,0,0,SD,after Ibrutinib,,M,08/06/1955,,31/03/2014,01/03/2008,CLL,AKH,,II,B,1,,,,,,28/11/2013,,SD,25/03/2015,,28/11/2013,,,,,,,,,,,,,,,,,,,14,0,27/09/2011,,,,,,,17/01/2014,154,,normal,,5000000,,94.54
CLL_ATAC-seq_AKH14_M4703_ATAC40s23_hg19,1,CLL,ATAC-seq,,AKH14,M4703,,,,ATAC40,ATAC40s23,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4703_M4703_ATAC40s23,vienna,patient,CLL,in_vivo,CLL11,1,AKH14-Ibrutinib,1,before,0,1,1,0,SD,before Ibrutinib,,F,04/05/1938,,19/08/2014,01/01/2006,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,91,1,1,0,24/04/2013,,,,,,,19/08/2014,67,,"del13p (80% no signal), del17p (90%)",,5000000,,96.03
CLL_ATAC-seq_AKH15_M4017_ATAC40s26_hg19,1,CLL,ATAC-seq,,AKH15,M4017,,,,ATAC40,ATAC40s26,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4017_M4017_ATAC40s26,vienna,patient,CLL,in_vivo,CLL21,2,AKH15-Revlimid+CC292,0,,,,,,SD,after Revlimid+CC292,,M,18/06/1952,,15/05/2014,01/04/2008,CLL,AKH,,IV,C,1,,,,,,28/11/2013,,SD,25/03/2015,,28/11/2013,,,,,,,,,,,,,,,,,100,0,19,0,04/11/2008,,,,,,,29/11/2013,37,,,,5000000,,93.82
CLL_ATAC-seq_AKH15_M4044_ATAC40s27_hg19,1,CLL,ATAC-seq,,AKH15,M4044,,,,ATAC40,ATAC40s27,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4044_M4044_ATAC40s27,vienna,patient,CLL,in_vivo,CLL21,3,AKH15-Revlimid+CC292,0,,,,,,SD,after Revlimid+CC292,,M,18/06/1952,,15/05/2014,01/04/2008,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,19,0,04/11/2008,,,,,,,27/12/2013,78,,,,5000000,,96
CLL_ATAC-seq_AKH15_M4278_ATAC40s28_hg19,1,CLL,ATAC-seq,,AKH15,M4278,,,,ATAC40,ATAC40s28,,human,bsf,BSF_0197_H5JTNBBXX,7,CLL_ATACseq_M4278_M4278_ATAC40s28,vienna,patient,CLL,in_vivo,CLL21,4,AKH15-Revlimid+CC292,0,,,,,,SD,after Revlimid+CC292,,M,18/06/1952,,15/05/2014,01/04/2008,CLL,AKH,,IV,C,1,,,,,,31/03/2015,,SD,,,31/03/2015,,,,,,,,,,,,,,,,,100,0,19,0,04/11/2008,,,,,,,12/06/2014,17.2,,del17p (95%),,5000000,,96.18
CLL_ATAC-seq_AKH15_M4537_ATAC43s2_hg19,1,CLL,ATAC-seq,,AKH15,M4537,,,,ATAC43,ATAC43s2,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4537_M4537_ATAC43s2_S12644,vienna,patient,CLL,in_vivo,CLL21,6,AKH15-Ibrutinib,1,after,0,0,0,0,SD,after Ibrutinib,,M,18/06/1952,,15/05/2014,01/04/2008,CLL,AKH,,IV,C,1,,,,,,13/11/2013,,SD,12/12/2014,,13/11/2013,,,,,,,,,,,,,,,,,100,0,19,0,04/11/2008,,,,,,,23/04/2015,8.6,,,,5000000,,89.32
CLL_ATAC-seq_AKH15_M4707_ATAC43s1_hg19,1,CLL,ATAC-seq,,AKH15,M4707,,,,ATAC43,ATAC43s1,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4707_M4707_ATAC43s1_S12643,vienna,patient,CLL,in_vivo,CLL21,5,AKH15-Ibrutinib,1,before,0,0,0,0,SD,after Revlimid+CC292 before Ibrutinib,,M,18/06/1952,,15/05/2014,01/04/2008,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,19,0,04/11/2008,,,,,,,27/11/2014,13.4,,,,5000000,,97.18
CLL_ATAC-seq_AKH16_M4717_ATAC43s3_hg19,1,CLL,ATAC-seq,,AKH16,M4717,,,,ATAC43,ATAC43s3,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4717_M4717_ATAC43s3_S12645,vienna,patient,CLL,in_vivo,CLL12,1,AKH16-Ibrutinib,1,before,0,0,0,0,PR,before Ibrutinib,,M,02/11/1943,,10/04/2014,20/2/2002,CLL,AKH,,IV,C,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,100,0,66,1,20/02/2002,,,,,,,05/02/2015,115,,normal,,5000000,,95.15
CLL_ATAC-seq_AKH16_M4721_ATAC43s4_hg19,1,CLL,ATAC-seq,,AKH16,M4721,,,,ATAC43,ATAC43s4,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4721_M4721_ATAC43s4_S12646,vienna,patient,CLL,in_vivo,CLL12,2,AKH16-Ibrutinib,1,after,0,0,0,0,PR,after Ibrutinib,,M,02/11/1943,,10/04/2014,20/2/2002,CLL,AKH,,IV,C,1,,,,,,26/06/2014,,PR,14/08/2015,,26/06/2014,,,,,,,,,,,,,,,,,100,0,66,1,20/02/2002,,,,,,,28/04/2015,112,,,,5000000,,92.27
CLL_ATAC-seq_AKH17_M4701_ATAC43s5_hg19,1,CLL,ATAC-seq,,AKH17,M4701,,,,ATAC43,ATAC43s5,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4701_M4701_ATAC43s5_S12647,vienna,patient,CLL,in_vivo,CLL13,1,AKH17-Ibrutinib,1,before,0,1,0,0,SD,before Ibrutinib,,F,03/08/1954,,25/05/2014,01/02/2004,CLL,AKH,,II,B,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,73,1,18/04/2013,,,,,,,26/06/2014,103,,del13p (60%),,5000000,,97.16
CLL_ATAC-seq_AKH17_M4711_ATAC43s6_hg19,1,CLL,ATAC-seq,,AKH17,M4711,,,,ATAC43,ATAC43s6,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4711_M4711_ATAC43s6_S12648,vienna,patient,CLL,in_vivo,CLL13,2,AKH17-Ibrutinib,1,after,0,1,0,0,SD,after Ibrutinib,,F,03/08/1954,alive,25/05/2014,01/02/2004,CLL,AKH,,II,B,1,,,,,,08/05/2014,,SD,16/01/2015,,08/05/2014,,,,,,,,,,,,,,,,,100,0,73,1,18/04/2013,,,,,,,09/12/2014,15.48,,,,5000000,,94.48
CLL_ATAC-seq_AKH18_M4697_ATAC43s7_hg19,1,CLL,ATAC-seq,,AKH18,M4697,,,,ATAC43,ATAC43s7,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4697_M4697_ATAC43s7_S12649,vienna,patient,CLL,in_vivo,CLL14,1,AKH18-Ibrutinib,1,before,0,1,1,0,SD,before Ibrutinib,,M,15/08/1954,21/05/2015,09/04/2015,01/09/2000,CLL,AKH,,II,B,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,91,1,1,0,14/01/2013,,,,,,,23/04/2014,97.5,,"del13p (92% no signal), del17p (75%)",,5000000,,97.25
CLL_ATAC-seq_AKH18_M4700_ATAC43s8_hg19,1,CLL,ATAC-seq,,AKH18,M4700,,,,ATAC43,ATAC43s8,,human,bsf,BSF_0207_H5JL7BBXX,5,CLL_ATACseq_M4700_M4700_ATAC43s8_S12650,vienna,patient,CLL,in_vivo,CLL14,2,AKH18-Ibrutinib,1,after,0,1,1,0,SD,after Ibrutinib,,M,15/08/1954,21/05/2015,09/04/2015,01/09/2000,CLL,AKH,,II,B,1,,,,,,10/03/2015,,SD,,,10/03/2015,,,,,,,,,,,,,,,,,91,1,1,0,14/01/2013,,,,,,,17/06/2014,309,,,,5000000,,91.65
CLL_ATAC-seq_AKH2_M4687_ATAC39s7_hg19,1,CLL,ATAC-seq,,AKH2,M4687,,,,ATAC39,ATAC39s7,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4687_M4687_ATAC39s7,vienna,patient,CLL,in_vivo,CLL1,2,AKH2-Ibrutinib,1,after,1,1,0,0,SD,after Ibrutinib,,M,03/05/1959,,26/04/2013,22/03/2011,CLL,AKH,,II,B,1,,,,,,15/01/2013,,SD,,,15/01/2013,,,,,,,,,,,,,,,,,100,0,93,1,22/03/2011,,,,,,,07/03/2013,7.3,,,,5000000,,95.64
CLL_ATAC-seq_AKH2_M4732_ATAC39s6_hg19,1,CLL,ATAC-seq,,AKH2,M4732,,,,ATAC39,ATAC39s6,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4732_M4732_ATAC39s6,vienna,patient,CLL,in_vivo,CLL1,1,AKH2-Ibrutinib,1,before,1,1,0,0,SD,before Ibrutinib,,M,03/05/1959,,26/04/2013,22/03/2011,CLL,AKH,,II,B,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,93,1,22/03/2011,,,,,,,14/01/2013,15.3,,"del13 (84%), del11q (94%)",,5000000,,66.47
CLL_ATAC-seq_AKH22_M4575_ATAC42s17_hg19,1,CLL,ATAC-seq,,AKH22,M4575,,,,ATAC42,ATAC42s17,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4575_M4575_ATAC42s17_S12617,vienna,patient,CLL,in_vivo,CLL22,11,AKH22-Zydelig+Rituximab,0,,,,,,SD,after Zydelig+Rituximab,,M,29/09/1957,,28/09/2015,01/12/2004,CLL,AKH,,IV,C,1,,,,,,12/08/2013,,SD,20/05/2014,,12/08/2013,,,,,,,,,,,,,,,,,97,1,87,1,20/08/2012,,,,,,,28/09/2015,68.7,,,,5000000,,90.16
CLL_ATAC-seq_AKH22_M4718_ATAC42s15_hg19,1,CLL,ATAC-seq,,AKH22,M4718,,,,ATAC42,ATAC42s15,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4718_M4718_ATAC42s15_S12615,vienna,patient,CLL,in_vivo,CLL22,9,AKH22-Zydelig+Rituximab,0,,,,,,SD,after Zydelig,,M,29/09/1957,,28/09/2015,01/12/2004,CLL,AKH,,IV,C,1,,,,,,22/12/2014,,SD,29/10/2015,,22/12/2014,,,,,,,,,,,,,,,,,97,1,87,1,20/08/2012,,,,,,,16/02/2015,142.28,,,,5000000,,95.23
CLL_ATAC-seq_AKH22_M4730_ATAC42s16_hg19,1,CLL,ATAC-seq,,AKH22,M4730,,,,ATAC42,ATAC42s16,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4730_M4730_ATAC42s16_S12616,vienna,patient,CLL,in_vivo,CLL22,10,AKH22-Zydelig+Rituximab,0,,,,,,SD,after Zydelig+Rituximab,,M,29/09/1957,,28/09/2015,01/12/2004,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,97,1,87,1,20/08/2012,,,,,,,31/08/2015,50.64,,,,5000000,,
CLL_ATAC-seq_AKH23_M3885_ATAC42s18_hg19,1,CLL,ATAC-seq,,AKH23,M3885,,,,ATAC42,ATAC42s18,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M3885_M3885_ATAC42s18_S12618,vienna,patient,CLL,in_vivo,CLL23,1,AKH23-Revlimid,0,,,,,,,before Revlimid,,M,15/05/1952,01/07/2014,22/04/2014,01/01/2004,CLL,AKH,,IV,C,1,,,,,,12/08/2013,,,20/05/2014,,12/08/2013,,,,,,,,,,,,,,,,,100,0,34,1,22/07/2013,,,,,,,12/08/2013,42.55,,"del17p (87%), tri12 (85%)",,5000000,,93.31
CLL_ATAC-seq_AKH23_M3889_ATAC42s19_hg19,1,CLL,ATAC-seq,,AKH23,M3889,,,,ATAC42,ATAC42s19,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M3889_M3889_ATAC42s19_S12619,vienna,patient,CLL,in_vivo,CLL23,2,AKH23-Revlimid,0,,,,,,,after Revlimid,,M,15/05/1952,01/07/2014,22/04/2014,01/01/2004,CLL,AKH,,IV,C,1,,,,,,12/08/2013,,,20/05/2014,,12/08/2013,,,,,,,,,,,,,,,,,100,0,34,1,22/07/2013,,,,,,,13/08/2013,32.28,,,,5000000,,92.09
CLL_ATAC-seq_AKH23_M3913_ATAC42s20_hg19,1,CLL,ATAC-seq,,AKH23,M3913,,,,ATAC42,ATAC42s20,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M3913_M3913_ATAC42s20_S12620,vienna,patient,CLL,in_vivo,CLL23,3,AKH23-Revlimid+CC292,0,,,,,,PD,after Revlimid+CC292,,M,15/05/1952,01/07/2014,22/04/2014,01/01/2004,CLL,AKH,,IV,C,0,,,,,,,,PD,,,,,,,,,,,,,,,,,,,,100,0,34,1,22/07/2013,,,,,,,09/09/2013,43.6,,,,5000000,,91.7
CLL_ATAC-seq_AKH23_M4097_ATAC42s21_hg19,1,CLL,ATAC-seq,,AKH23,M4097,,,,ATAC42,ATAC42s21,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4097_M4097_ATAC42s21_S12621,vienna,patient,CLL,in_vivo,CLL23,4,AKH23-Revlimid+CC292,0,,,,,,,after Revlimid+CC292,,M,15/05/1952,01/07/2014,22/04/2014,01/01/2004,CLL,AKH,,IV,C,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,34,1,22/07/2013,,,,,,,14/02/2014,44.79,,"del17p (90%), tri12 (56%)",,5000000,,91.74
CLL_ATAC-seq_AKH23_M4698_ATAC42s22_hg19,1,CLL,ATAC-seq,,AKH23,M4698,,,,ATAC42,ATAC42s22,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4698_M4698_ATAC42s22_S12622,vienna,patient,CLL,in_vivo,CLL23,5,AKH23-Revlimid+CC292,0,,,,,,PR,after Revlimid+CC292,,M,15/05/1952,01/07/2014,22/04/2014,01/01/2004,CLL,AKH,,IV,C,1,,,,,,18/04/2013,,PR,26/09/2013,,18/04/2013,,,,,,,,,,,,,,,,,100,0,34,1,22/07/2013,,,,,,,05/06/2014,27.88,,"del17p(98%), tri12 (85%)",,5000000,,92.38
CLL_ATAC-seq_AKH24_M3763_ATAC42s23_hg19,1,CLL,ATAC-seq,,AKH24,M3763,,,,ATAC42,ATAC42s23,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M3763_M3763_ATAC42s23_S12623,vienna,patient,CLL,in_vivo,CLL24,1,AKH24-TRU+Benda,0,,,,,,,before TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,1,,,,,,18/04/2013,,,26/09/2013,,18/04/2013,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,18/04/2013,247,,"del13p (85%), ATM (79%)",,5000000,,90.33
CLL_ATAC-seq_AKH24_M4573_ATAC42s28_hg19,1,CLL,ATAC-seq,,AKH24,M4573,,,,ATAC42,ATAC42s28,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4573_M4573_ATAC42s28_S12628,vienna,patient,CLL,in_vivo,CLL24,6,AKH24-TRU+Benda,0,,,,,,,after TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,24/09/2015,251.97,,"del13p (90%), del11q (90%)",,5000000,,90.24
CLL_ATAC-seq_AKH24_M4689_ATAC42s24_hg19,1,CLL,ATAC-seq,,AKH24,M4689,,,,ATAC42,ATAC42s24,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4689_M4689_ATAC42s24_S12624,vienna,patient,CLL,in_vivo,CLL24,2,AKH24-TRU+Benda,0,,,,,,CR,after TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,0,,,,,,,,CR,,,,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,16/05/2013,5,,,,3400000,,
CLL_ATAC-seq_AKH24_M4690_ATAC42s25_hg19,1,CLL,ATAC-seq,,AKH24,M4690,,,,ATAC42,ATAC42s25,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4690_M4690_ATAC42s25_S12625,vienna,patient,CLL,in_vivo,CLL24,3,AKH24-TRU+Benda,0,,,,,,,after TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,26/09/2013,4,,,,300000,,
CLL_ATAC-seq_AKH24_M4695_ATAC42s26_hg19,1,CLL,ATAC-seq,,AKH24,M4695,,,,ATAC42,ATAC42s26,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4695_M4695_ATAC42s26_S12626,vienna,patient,CLL,in_vivo,CLL24,4,AKH24-TRU+Benda,0,,,,,,PD (11.9.14),after TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,0,,,,,,,,PD (11.9.14),,,,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,06/02/2014,5.6,,,,5000000,,74.42
CLL_ATAC-seq_AKH24_M4712_ATAC42s27_hg19,1,CLL,ATAC-seq,,AKH24,M4712,,,,ATAC42,ATAC42s27,,human,bsf,BSF_0207_H5JL7BBXX,3,CLL_ATACseq_M4712_M4712_ATAC42s27_S12627,vienna,patient,CLL,in_vivo,CLL24,5,AKH24-TRU+Benda,0,,,,,,,after TRU+Benda,,F,10/07/1941,,24/09/2015,01/10/1999,CLL,AKH,,II,B,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,38,1,18/04/2013,,,,,,,11/12/2014,31.28,,,,5000000,,97.81
CLL_ATAC-seq_AKH3_M4683_ATAC39s9_hg19,1,CLL,ATAC-seq,,AKH3,M4683,,,,ATAC39,ATAC39s9,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4683_M4683_ATAC39s9,vienna,patient,CLL,in_vivo,CLL2,2,AKH3-Ibrutinib,1,after,0,1,1,0,PR,after Ibrutinib,,M,30/09/1953,,13/10/2015,01/02/2007,CLL,AKH,,I,A,1,,,,,,01/09/2014,,PR,,,01/09/2014,,,,,,,,,,,,,,,,,100,0,2,0,19/02/2007,,,,,,,12/02/2013,73,,,,5000000,,95.86
CLL_ATAC-seq_AKH3_M4733_ATAC39s8_hg19,1,CLL,ATAC-seq,,AKH3,M4733,,,,ATAC39,ATAC39s8,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4733_M4733_ATAC39s8,vienna,patient,CLL,in_vivo,CLL2,1,AKH3-Ibrutinib,1,before,0,1,1,0,PR,before Ibrutinib,,M,30/09/1953,,13/10/2015,01/02/2007,CLL,AKH,,I,A,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,100,0,2,0,19/02/2007,,,,,,,07/01/2013,61,,"del13 (80%, del17p (85%)",,5000000,,89.45
CLL_ATAC-seq_AKH4_M4378_ATAC39s12_hg19,1,CLL,ATAC-seq,,AKH4,M4378,,,,ATAC39,ATAC39s12,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4378_M4378_ATAC39s12,vienna,patient,CLL,in_vivo,CLL19,1,AKH4-Zydelig,0,,,,,,,before Zydelig,,M,07/07/1949,,08/10/2015,01/10/1996,CLL,AKH,,II,B,1,,,,,,17/03/2015,,,,,17/03/2015,,,,,,,,,,,,,,,,,100,0,33,1,18/07/2013,,,,,,,16/09/2014,217,,"del17p (15%), del13p (93%) ",,5000000,,88.53
CLL_ATAC-seq_AKH4_M4521_ATAC39s13_hg19,1,CLL,ATAC-seq,,AKH4,M4521,,,,ATAC39,ATAC39s13,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4521_M4521_ATAC39s13,vienna,patient,CLL,in_vivo,CLL19,3,AKH4-Zydelig,1,before,0,0,0,0,SD,after Zydelig before Ibrutinib,,M,07/07/1949,,08/10/2015,01/10/1996,CLL,AKH,,II,B,1,,,,,,17/03/2015,,SD,,,17/03/2015,,,,,,,,,,,,,,,,,100,0,33,1,18/07/2013,,,,,,,17/03/2015,203,,,,5000000,,93.18
CLL_ATAC-seq_AKH4_M4552_ATAC39s14_hg19,1,CLL,ATAC-seq,,AKH4,M4552,,,,ATAC39,ATAC39s14,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4552_M4552_ATAC39s14,vienna,patient,CLL,in_vivo,CLL19,5,AKH4-Ibrutinib,1,after,0,0,0,0,SD,after Ibrutinib,,M,07/07/1949,,08/10/2015,01/10/1996,CLL,AKH,,II,B,1,,,,,,27/09/2011,,SD,27/02/2012,,27/09/2011,,,,,,,,,,,,,,,,,100,0,33,1,18/07/2013,,,,,,,19/05/2015,137,,,,5000000,,92
CLL_ATAC-seq_AKH4_M4709_ATAC39s10_hg19,1,CLL,ATAC-seq,,AKH4,M4709,,,,ATAC39,ATAC39s10,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4709_M4709_ATAC39s10,vienna,patient,CLL,in_vivo,CLL19,2,AKH4-Zydelig,0,,,0,0,0,,after Zydelig,,M,07/07/1949,,08/10/2015,01/10/1996,CLL,AKH,,II,B,1,,,,,,17/03/2015,,,,,17/03/2015,,,,,,,,,,,,,,,,,100,0,33,1,18/07/2013,,,,,,,09/12/2014,217,,,,5000000,,92.26
CLL_ATAC-seq_AKH4_M4722_ATAC39s11_hg19,1,CLL,ATAC-seq,,AKH4,M4722,,,,ATAC39,ATAC39s11,,human,bsf,BSF_0197_H5JTNBBXX,2,CLL_ATACseq_M4722_M4722_ATAC39s11,vienna,patient,CLL,in_vivo,CLL19,4,AKH4-Ibrutinib,1,after,0,0,0,0,SD,after Ibrutinib,,M,07/07/1949,,08/10/2015,01/10/1996,CLL,AKH,,II,B,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,33,1,18/07/2013,,,,,,,28/04/2015,178,,,,5000000,,96.01
CLL_ATAC-seq_AKH5_M4702_ATAC40s1_hg19,1,CLL,ATAC-seq,,AKH5,M4702,,,,ATAC40,ATAC40s1,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4702_M4702_ATAC40s1,vienna,patient,CLL,in_vivo,CLL3,1,AKH5-Ibrutinib,1,before,0,0,1,1,PR,before Ibrutinib,,F,06/07/1940,,25/04/2014,29/03/2004,CLL,AKH,,I,A,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,100,0,33,1,17/07/2014,,,,,,,17/07/2014,186,,"del17p (12%), tri12 (54%)",,5000000,,98.24
CLL_ATAC-seq_AKH5_M4706_ATAC40s2_hg19,1,CLL,ATAC-seq,,AKH5,M4706,,,,ATAC40,ATAC40s2,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4706_M4706_ATAC40s2,vienna,patient,CLL,in_vivo,CLL3,2,AKH5-Ibrutinib,1,after,0,0,1,1,PR,after Ibrutinib,,F,06/07/1940,,25/04/2014,29/03/2004,CLL,AKH,,I,A,1,,,,,,26/02/2015,,PR,,,26/02/2015,,,,,,,,,,,,,,,,,100,0,33,1,17/07/2014,,,,,,,11/11/2014,39,,,,5000000,,96.38
CLL_ATAC-seq_AKH6_M4716_ATAC40s3_hg19,1,CLL,ATAC-seq,,AKH6,M4716,,,,ATAC40,ATAC40s3,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4716_M4716_ATAC40s3,vienna,patient,CLL,in_vivo,CLL4,1,AKH6-Ibrutinib,1,before,0,1,0,1,PR,before Ibrutinib,,F,11/03/1943,,06/06/2014,01/01/2006,CLL,AKH,,I,A,0,,,,,,,,PR,,,,,,,,,,,,,,,,,,,,95,1,7,0,04/02/2008,,,,,,,03/02/2015,30.86,,"del13q (10%), tri12 (42%)",,2800000,,
CLL_ATAC-seq_AKH6_M4726_ATAC40s4_hg19,1,CLL,ATAC-seq,,AKH6,M4726,,,,ATAC40,ATAC40s4,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4726_M4726_ATAC40s4,vienna,patient,CLL,in_vivo,CLL4,2,AKH6-Ibrutinib,1,after,0,1,0,1,PR,after Ibrutinib,,F,11/03/1943,,06/06/2014,01/01/2006,CLL,AKH,,I,A,1,,,,,,28/01/2013,,PR,,,28/01/2013,,,,,,,,,,,,,,,,,95,1,7,0,04/02/2008,,,,,,,26/05/2015,5.61,,,,5000000,,91.46
CLL_ATAC-seq_AKH7_M4685_ATAC40s6_hg19,1,CLL,ATAC-seq,,AKH7,M4685,,,,ATAC40,ATAC40s6,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4685_M4685_ATAC40s6,vienna,patient,CLL,in_vivo,CLL5,2,AKH7-Ibrutinib,1,after,0,1,1,1,SD,after Ibrutinib,,M,29/04/1952,,29/10/2015,01/01/2005,CLL,AKH,,I,A,1,,,,,,16/10/2014,,SD,,,16/10/2014,,,,,,,,,,,,,,,,,100,0,90,1,14/01/2013,,,,,,,25/02/2013,28,,,,5000000,,97.17
CLL_ATAC-seq_AKH7_M4734_ATAC40s5_hg19,1,CLL,ATAC-seq,,AKH7,M4734,,,,ATAC40,ATAC40s5,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4734_M4734_ATAC40s5,vienna,patient,CLL,in_vivo,CLL5,1,AKH7-Ibrutinib,1,before,0,1,1,0,SD,before Ibrutinib,,M,29/04/1952,,29/10/2015,01/01/2005,CLL,AKH,,I,A,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,100,0,90,1,14/01/2013,,,,,,,21/01/2013,243,,"del13p (79%), del17p (86%)",,5000000,,92.65
CLL_ATAC-seq_AKH8_M4704_ATAC40s7_hg19,1,CLL,ATAC-seq,,AKH8,M4704,,,,ATAC40,ATAC40s7,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4704_M4704_ATAC40s7,vienna,patient,CLL,in_vivo,CLL6,1,AKH8-Ibrutinib,1,before,0,1,1,0,SD,before Ibrutinib,,F,13/07/1939,,27/08/2013,01/01/1987,CLL,AKH,,IV,C,0,,,,,,,,SD,,,,,,,,,,,,,,,,,,,,,,76,1,07/06/2013,,,,,,,16/10/2014,270,,"del13p (87%), del17p (87%)",,5000000,,97.39
CLL_ATAC-seq_AKH8_M4708_ATAC40s8_hg19,1,CLL,ATAC-seq,,AKH8,M4708,,,,ATAC40,ATAC40s8,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4708_M4708_ATAC40s8,vienna,patient,CLL,in_vivo,CLL6,2,AKH8-Ibrutinib,1,after,0,1,1,0,SD,after Ibrutinib,,F,13/07/1939,,27/08/2013,01/01/1987,CLL,AKH,,IV,C,1,,,,,,23/12/2014,,SD,,,23/12/2014,,,,,,,,,,,,,,,,,,,76,1,07/06/2013,,,,,,,27/11/2014,189,,,,5000000,,95.37
CLL_ATAC-seq_AKH9_M4714_ATAC40s9_hg19,1,CLL,ATAC-seq,,AKH9,M4714,,,,ATAC40,ATAC40s9,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4714_M4714_ATAC40s9,vienna,patient,CLL,in_vivo,CLL7,1,AKH9-Ibrutinib,1,before,0,1,0,0,,before Ibrutinib,,M,30/01/1951,,23/05/2013,29/03/2011,CLL,AKH,,IV,C,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100,0,66,1,29/03/2011,,,,,,,22/12/2014,72.6,,del13p (80%),,5000000,,96.89
CLL_ATAC-seq_AKH9_M4715_ATAC40s10_hg19,1,CLL,ATAC-seq,,AKH9,M4715,,,,ATAC40,ATAC40s10,,human,bsf,BSF_0197_H5JTNBBXX,6,CLL_ATACseq_M4715_M4715_ATAC40s10,vienna,patient,CLL,in_vivo,CLL7,2,AKH9-Ibrutinib,1,after,0,1,0,0,,after Ibrutinib,,M,30/01/1951,,23/05/2013,29/03/2011,CLL,AKH,,IV,C,1,,,,,,20/10/2014,,,,,20/10/2014,,,,,,,,,,,,,,,,,100,0,66,1,29/03/2011,,,,,,,15/01/2015,40.4,,,,5000000,,97.85
